Cancer Genetics tests in Dubai & UAE

Compare available Cancer Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–6,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Genetics test prices

Showing 31–45 of 59 matching tests.

Cancer Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2004 MN1 Gene Meningioma & MN1 Deficiency Genetic Test This test evaluates the MN1 gene for mutations associated with an increased risk of developing meningioma and MN1-deficiency syndromes.	Peripheral whole blood (venous or dried blood spot [FTA card])	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MN1 gene mutations", "Germline variants", "Somatic variants"] Parameters [] Preparation [] Indications ["Family history of meningioma", "Personal history suggestive of meningioma", "Assessment of hereditary cancer risk"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Z15.09 Clinical summary This test evaluates the MN1 gene for mutations associated with an increased risk of developing meningioma and MN1-deficiency syndromes.
TEST-2072 MSH6 Gene Endometrial Cancer, Familial, MSH6-Related Genetic Test This test evaluates the MSH6 gene for mutations associated with hereditary endometrial cancer and Lynch syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MSH6 gene mutations", "DNA mismatch repair protein function"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Pre-cancer surveillance in high-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: Z15.09 Clinical summary This test evaluates the MSH6 gene for mutations associated with hereditary endometrial cancer and Lynch syndrome.
TEST-2067 MUTYH Gene Familial Adenomatous Polyposis Type 2 Genetic Test This genetic test identifies pathogenic mutations in the MUTYH gene associated with an increased risk of colorectal cancer.	Peripheral whole blood or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MUTYH gene sequence", "Copy Number Variations (CNVs) in MUTYH gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Individuals with a personal or family history suggestive of MUTYH-associated polyposis (MAP)", "Screening for hereditary colorectal cancer risk"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D12.6 Clinical summary This genetic test identifies pathogenic mutations in the MUTYH gene associated with an increased risk of colorectal cancer.
TEST-2069 NDUFA13 Genetic Test for Hurthle Cell Thyroid Carcinoma This test evaluates for germline mutations in the NDUFA13 gene, which are associated with an increased hereditary risk of Hurthle cell thyroid carcinoma.	Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the NDUFA13 gene"] Parameters [] Preparation ["Do not discontinue prescribed thyroid medication, hormone therapy, or anticoagulant regimen without consulting your referring physician."] Indications ["Individuals with a personal or family history of thyroid cancer", "Assessment of hereditary risk for Hurthle cell thyroid carcinoma"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: C73 Clinical summary This test evaluates for germline mutations in the NDUFA13 gene, which are associated with an increased hereditary risk of Hurthle cell thyroid carcinoma.
TEST-2687 NRAS Mutation Analysis (Codons 12, 13, and 61) Test This test detects specific mutations in the NRAS gene (codons 12, 13, 61) within tumor tissue.	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Archival Specimen	6 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NRAS gene mutations (codons 12, 13, 61)", "Activating single-nucleotide variants"] Parameters [] Preparation [] Indications ["Guiding anti-EGFR therapy in colorectal cancer", "Prognostication in melanoma", "Prognostication in acute myeloid leukemia"] Measurement technique Confirm with laboratory Codes LOINC: 48767-7 ICD-10: C18.9 Clinical summary This test detects specific mutations in the NRAS gene (codons 12, 13, 61) within tumor tissue.
TEST-2089 NTHL1 Gene Familial Adenomatous Polyposis Type 3 Genetic Test This genetic test evaluates the NTHL1 gene for mutations associated with familial adenomatous polyposis type 3.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NTHL1 gene mutations", "Germline variants"] Parameters [] Preparation ["No fasting required", "Provide detailed family cancer history", "Attend genetic counselling session"] Indications ["Suspected hereditary colorectal cancer syndrome", "Family history of familial adenomatous polyposis type 3"] Measurement technique Confirm with laboratory Codes LOINC: 58130-9 ICD-10: Z15.09 Clinical summary This genetic test evaluates the NTHL1 gene for mutations associated with familial adenomatous polyposis type 3.
TEST-2150 OncoDx Panel Genetic Test This test evaluates genetic variations in 67 genes associated with hereditary cancer syndromes.	Peripheral whole blood (8–10 mL in EDTA lavender-top tube)	3–4 weeks from sample receipt at laboratory	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variations (SNPs, indels, CNVs) in 67 cancer-related genes", "Hereditary cancer risk"] Parameters [] Preparation ["No specific fasting required", "Inform the phlebotomist of any medications being taken"] Indications ["Individuals with a personal or family history suggestive of hereditary cancer syndrome", "Risk assessment for breast, ovarian, colorectal, endometrial, pancreatic, and endocrine malignancies", "Guiding personalised screening and prevention strategies"] Measurement technique Confirm with laboratory Codes LOINC: 94282-2 ICD-10: Z15.09, Z80.3, Z80.0 Clinical summary This test evaluates genetic variations in 67 genes associated with hereditary cancer syndromes.
TEST-2803 OncoPro BRAF Rapid Test This test detects the presence of the BRAF V600E mutation in FFPE tumor tissue.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block	2 working days	2,900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF V600E mutation (c.1799T>A)", "Somatic Mutation Detection"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (validated for FFPE)"}, {"name": "Minimum Tumor Content", "reference_range": "≥10%"}] Preparation ["No patient preparation is required."] Indications ["Guidance for targeted therapy in melanoma", "Guidance for targeted therapy in colorectal carcinoma", "Guidance for targeted therapy in non-small cell lung cancer"] Measurement technique Confirm with laboratory Codes LOINC: 59041-3 ICD-10: C43.9, C18.9, C34.9 Clinical summary This test detects the presence of the BRAF V600E mutation in FFPE tumor tissue.
TEST-2122 PALB2 Gene Breast Cancer Susceptibility Genetic Test This genetic test evaluates the PALB2 gene for pathogenic variants associated with increased breast and pancreatic cancer risk.	Peripheral whole blood	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PALB2 gene coding region variants", "Germline mutations"] Parameters [] Preparation [] Indications ["Personal or family history of breast cancer", "Personal or family history of pancreatic cancer", "Individuals seeking hereditary cancer risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94083-9 ICD-10: Z15.01 Clinical summary This genetic test evaluates the PALB2 gene for pathogenic variants associated with increased breast and pancreatic cancer risk.
TEST-1990 PDGFB Gene Familial Meningioma Genetic Test This test evaluates the entire coding region of the PDGFB gene for germline mutations associated with hereditary meningioma.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFB gene mutations", "Point mutations", "Small insertions/deletions", "Copy-number variations"] Parameters [] Preparation [] Indications ["Personal or family history of meningioma", "Known PDGFB-related syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09 Clinical summary This test evaluates the entire coding region of the PDGFB gene for germline mutations associated with hereditary meningioma.
TEST-1996 PMS2 Gene Genetic Test for Lynch Syndrome This genetic test evaluates for mutations in the PMS2 gene, a key component of the DNA mismatch repair system, associated with an increased risk of Lynch syndrome.	Whole Blood (EDTA) or Extracted DNA or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PMS2 gene mutations", "DNA mismatch repair deficiency"] Parameters [] Preparation ["No fasting is necessary"] Indications ["Individuals with a personal or family history of colorectal or endometrial cancer before age 50", "Individuals with multiple Lynch-spectrum cancers in the family", "Individuals with confirmed Lynch syndrome in a relative", "Individuals with tumours showing microsatellite instability", "Asymptomatic adults seeking risk clarification (preceded by genetic counselling)"] Measurement technique Confirm with laboratory Codes LOINC: 21669-3 ICD-10: Z15.09 Clinical summary This genetic test evaluates for mutations in the PMS2 gene, a key component of the DNA mismatch repair system, associated with an increased risk of Lynch syndrome.
TEST-2073 RAD50 Gene Hereditary Breast and Ovarian Cancer Syndrome (HBOC) Test This genetic test evaluates the RAD50 gene for pathogenic variants associated with an increased risk of hereditary breast and ovarian cancer.	Peripheral Whole Blood (EDTA tube)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RAD50 gene", "Copy number variants in the RAD50 gene"] Parameters [] Preparation [] Indications ["Strong family history of breast or ovarian cancer", "Multiple affected relatives", "Early-onset breast or ovarian cancer"] Measurement technique Confirm with laboratory Codes LOINC: 97765-3 ICD-10: Z15.01, Z15.02 Clinical summary This genetic test evaluates the RAD50 gene for pathogenic variants associated with an increased risk of hereditary breast and ovarian cancer.
TEST-1967 RET Gene Multiple Endocrine Neoplasia Type 2B (MEN2B) Genetic Test This test analyzes the entire RET gene for mutations linked to Multiple Endocrine Neoplasia Type 2B (MEN2B), a hereditary cancer syndrome.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RET gene", "Presence of mutations associated with MEN2B"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Individuals with a family history of MEN2B", "Individuals with clinical features suggestive of MEN2B", "Individuals with elevated calcitonin levels"] Measurement technique Confirm with laboratory Codes LOINC: 21673-2 ICD-10: E31.22 Clinical summary This test analyzes the entire RET gene for mutations linked to Multiple Endocrine Neoplasia Type 2B (MEN2B), a hereditary cancer syndrome.
TEST-1882 RHBDF2 Gene Tylosis with Esophageal Cancer Genetic Test This genetic test evaluates the RHBDF2 gene for pathogenic variants associated with Tylosis with Esophageal Cancer syndrome.	Peripheral Whole Blood (EDTA)	21–28 Calendar Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RHBDF2 gene", "Copy Number Variations (CNV) in the RHBDF2 gene"] Parameters [{"name": "RHBDF2 Gene Analysis", "reference_range": "Negative for pathogenic variants"}] Preparation ["No specific fasting required", "Do not alter or stop any current medication without prior consultation with your treating physician"] Indications ["Individuals with a personal or family history suggestive of Tylosis with Esophageal Cancer syndrome", "Proactive cancer risk assessment in high-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 86223-0 ICD-10: Z15.09, Q82.8, C15.9 Clinical summary This genetic test evaluates the RHBDF2 gene for pathogenic variants associated with Tylosis with Esophageal Cancer syndrome.
TEST-2125 RINT1 Gene Breast Cancer Genetic Test This test evaluates the RINT1 gene for mutations associated with hereditary breast cancer and Lynch syndrome risk.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RINT1 gene mutations", "Hereditary cancer risk"] Parameters [] Preparation ["No fasting required"] Indications ["Personal or family history of breast cancer", "Personal or family history of Lynch syndrome-associated cancers", "Genetic counseling recommendation"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z15.01 Clinical summary This test evaluates the RINT1 gene for mutations associated with hereditary breast cancer and Lynch syndrome risk.

Category overview

Cancer Genetics: overview

Empowering yourself with a deep understanding of your family’s oncological history is the most effective way to protect your future wellness. As a core pillar of our advanced Molecular Genetics department, comprehensive Cancer Genetics screening provides an in-depth evaluation of the complex hereditary pathways linked to various cancer syndromes. By leveraging cutting-edge genomic technology, this expansive screening delivers the critical clarity required to assess inherited risks, safely guiding customized oncology oversight, specialized prophylactic strategies, and informed family planning. Consistently ranked among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable turnaround times. Prioritize your preventative health—book your cancer genetics testing in UAE, arrange a comfortable home sample collection, or consult our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.